KYAT1 and hepatocellular carcinoma: To study the endogenous KYAT1 activity we determined the half-maximal inhibitory concentration (IC50) in HCC cell lines in comparison with normal human hepatocytes, to establish a feasible study system of diverse responses generated by MSC treatment.